Healthcare, Pharma & Life Sciences

AGC Biologics Expands Heidelberg Microbial Capacity with VIP GMP Slots and Fixed Pricing for Late-Phase and Commercial Programs

Image

SHERIDAN, WYOMING - April 04, 2026 - Biopharmaceutical developers advancing late-phase and commercial microbial programs now face compounding risks from tariff volatility, supply chain fragility, and GMP slot scarcity - pressures that are reshaping how sponsors select and lock in CDMO partnerships heading into 2026 budget cycles.

Heidelberg capacity expansion and the VIP slot offer

AGC Biologics is expanding microbial manufacturing capacity at its Heidelberg facility and has opened a limited window of priority GMP slots for 10,000 L production runs at set pricing with pre-determined timelines. The offer targets late-phase and commercial developers who need to secure supply against market volatility and scheduling uncertainty. Terms and conditions apply, and the window is explicitly time-limited.

Perimeter Medical Imaging AI's Claire Earns First FDA PMA for AI-Enabled Breast Cancer Margin Assessment

SHERIDAN, WYOMING - April 03, 2026 - Perimeter Medical Imaging AI has secured FDA premarket approval (PMA) for Claire, making it the first AI-enabled imaging device cleared in the United States for intraoperative breast cancer margin assessment during lumpectomy procedures. Claire, previously marketed as the Perimeter OCT B-Series with ImgAssist AI 2.0, holds FDA Breakthrough Device designation and targets an estimated 300,000 annual U.S. breast-conserving surgeries where residual disease forces re-operations in roughly one in five cases. The approval positions Perimeter to launch a nationwide commercial rollout in the weeks following clearance, converting a clinical trial asset into a revenue-generating platform with expansion potential across additional cancer indications.

Henry Schein Engages Institutional Investors at Leerink and Barclays Healthcare Conferences

SHERIDAN, WYOMING - April 01, 2026 - Institutional investors evaluating healthcare distribution and dental supply chains gain a direct window into Henry Schein's strategic priorities as the company presents at two major sell-side healthcare conferences, signaling where management attention is focused for 2026 capital allocation and operational direction.

Conference participation details

Henry Schein, Inc. (Nasdaq: HSIC) presented at Leerink's Global Healthcare Conference at the W South Beach hotel in Miami on March 9, with a session starting at 10:00 a.m. EST. The following day, March 10, the company appeared at the Barclays 28th Annual Global Healthcare Conference, held at the Loews Miami Beach hotel, also in Miami, beginning at 10:30 a.m. EST.

Philips Launches Cloud-Enabled IntelliSite Pathology Solution on HealthSuite Powered by AWS

Image

SHERIDAN, WYOMING - April 01, 2026 - Pathology laboratories operating hybrid analog-digital environments face mounting pressure to eliminate on-premise infrastructure bottlenecks as image volumes grow and AI-enabled diagnostics move closer to routine clinical use. Philips' expansion of its digital pathology portfolio with the cloud-enabled Philips IntelliSite Pathology Solution (PIPS) on HealthSuite, powered by Amazon Web Services (AWS), directly addresses this operational gap by removing the requirement for local server infrastructure while enabling secure, remote access to high-resolution whole-slide images across distributed care sites.

MedTech Europe pushes for climate resilience rules that protect device supply and care access in the EU

Image

SHERIDAN, WYOMING - March 31, 2026 - Climate resilience planning is moving into 2026 healthcare procurement, regulatory, and supply-chain decisions as the European Commission develops an Integrated Climate Resilience Framework that could shape how medical technology manufacturers invest, document compliance, and maintain uninterrupted access to devices and diagnostics. In February 2026, MedTech Europe responded to the Commission's public consultation and argued for a holistic healthcare system response built on smart investments, better coordination, consistent policy frameworks, and improved collaboration across healthcare actors.

Dentsply Sirona ties sustainability, gender equality and dental practice support into its long-term operating agenda

Image

SHERIDAN, WYOMING - March 31, 2026 - Dental practice leaders and procurement teams face a clearer 2026 requirement to weigh supplier ESG performance, workforce equity and operational support alongside product selection, as Dentsply Sirona positions sustainability in dentistry as part of its core business model. On its German sustainability page, the company says its BEYOND strategy is built around reducing environmental footprint, improving oral health globally, creating an equitable, inclusive and respectful culture, and establishing processes for integrity, transparency and accountability. The framework is organized around three pillars: a healthy planet, a healthy smile and a healthy business. The page also links sustainability work to training, practice resources and support tools that dental professionals can use in day-to-day operations.

MedTech Europe uses WHX Dubai 2026 to push regulatory alignment and market access talks across the Middle East and Africa

Image

SHERIDAN, WYOMING - March 31, 2026 - Medical device companies assessing 2026 market access, compliance planning and regional expansion in the Middle East and Africa face a more policy-driven environment, as trade associations use WHX Dubai 2026 to shape discussion on regulatory frameworks, international alignment and patient access. MedTech Europe said it will be present at WHX Dubai 2026, formerly Arab Health, to engage policymakers, regulators and other stakeholders from across the Middle East, Africa and beyond on issues affecting the medical technology sector, with attention on how medical technologies can support patient access and resilient health systems across regions.

What the Senate action changes

SHERIDAN, WYOMING - March 31, 2026 - Early-stage medtech companies could regain a key non-dilutive funding route in 2026 after the Senate passed legislation to reauthorize the federal Small Business Innovation Research and Small Business Technology Transfer programs, reducing uncertainty that has persisted since the programs' authorization lapsed on September 30, 2025. AdvaMed said the Senate action restores momentum for grants that support early research and development at startups and small manufacturers, and it urged the House of Representatives to move quickly on passage. The association framed the programs as an important bridge for companies that struggle to finance next-generation device development before products reach patients or later-stage commercial milestones.

AdvaMed opens 2026 award nominations ahead of The MedTech Conference in Boston

SHERIDAN, WYOMING - March 31, 2026 - Medtech companies planning 2026 leadership recognition, industry positioning, and internal talent visibility now have a defined nomination window tied to one of the sector's highest-profile annual gatherings. AdvaMed has opened nominations through April 10 for three 2026 honors: the AdvaMed Lifetime Achievement Award, the AdvaMedDx Lifetime of Leadership & Service Award, and the AdvaMed Imaging Röntgen Award. All three awards are scheduled to be presented at The MedTech Conference, set for October 18-21, 2026, in Boston.

EU-India trade deal reshapes medical device tariff and compliance planning for 2026

Image

SHERIDAN, WYOMING - March 23, 2026 - Medical device procurement, market-entry, and sourcing decisions for 2026 shift as the EU-India Free Trade Agreement moves from negotiation to implementation, reducing tariff friction on most EU-made devices entering India and putting more weight on customs, conformity assessment, and regulatory execution. The agreement carries direct implications for patient access, market access, and competitiveness in the medical technology sector. For EU manufacturers and Indian buyers, the practical change is that a major cost barrier on cross-border device trade is set to ease while compliance and trade processes become a more important part of operational planning.